Iovance Biotherapeutics, Inc. (IOVA)
14.22
-0.02
(-0.11%)
USD |
NASDAQ |
Oct 02, 16:00
14.22
+0.01
(+0.07%)
After-Hours: 20:00
Iovance Biotherapeutics Market Cap : 6.439B for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 6.439B |
| October 01, 2026 | 6.446B |
| September 30, 2026 | 6.713B |
| September 29, 2026 | 6.545B |
| September 28, 2026 | 4.978B |
| September 25, 2026 | 4.983B |
| September 24, 2026 | 4.892B |
| September 23, 2026 | 4.616B |
| September 22, 2026 | 4.820B |
| September 21, 2026 | 4.616B |
| September 18, 2026 | 4.643B |
| September 17, 2026 | 4.539B |
| September 16, 2026 | 4.471B |
| September 15, 2026 | 4.240B |
| September 14, 2026 | 4.195B |
| September 11, 2026 | 3.896B |
| September 10, 2026 | 3.687B |
| September 09, 2026 | 3.819B |
| September 08, 2026 | 3.941B |
| September 04, 2026 | 3.982B |
| September 03, 2026 | 3.941B |
| September 02, 2026 | 3.905B |
| September 01, 2026 | 3.751B |
| August 31, 2026 | 3.701B |
| August 28, 2026 | 3.628B |
| Date | Value |
|---|---|
| August 27, 2026 | 3.742B |
| August 26, 2026 | 3.660B |
| August 25, 2026 | 3.823B |
| August 24, 2026 | 3.651B |
| August 21, 2026 | 3.755B |
| August 20, 2026 | 4.072B |
| August 19, 2026 | 3.619B |
| August 18, 2026 | 3.184B |
| August 17, 2026 | 3.216B |
| August 14, 2026 | 3.162B |
| August 13, 2026 | 2.953B |
| August 12, 2026 | 3.053B |
| August 11, 2026 | 2.940B |
| August 10, 2026 | 2.899B |
| August 07, 2026 | 2.872B |
| August 06, 2026 | 2.813B |
| August 05, 2026 | 1.966B |
| August 04, 2026 | 1.975B |
| August 03, 2026 | 1.890B |
| July 31, 2026 | 1.783B |
| July 30, 2026 | 2.055B |
| July 29, 2026 | 1.998B |
| July 28, 2026 | 2.059B |
| July 27, 2026 | 2.147B |
| July 24, 2026 | 2.186B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| AVITA Medical, Inc. | 393.39M |
| Amgen, Inc. | 217.88B |
| Halozyme Therapeutics, Inc. | 12.53B |
| Neurocrine Biosciences, Inc. | 14.55B |
| Editas Medicine, Inc. | 402.25M |
Market Cap Related Metrics
| PS Ratio | 17.93 |
| Price to Book Value | 8.748 |
| Price | 14.22 |
| Earnings Yield | -5.07% |